Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea

Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea - Prospective 9 Years Follow-up Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01475682

Enrollment

167

Registered

2011-11-21

Start date

2011-11-30

Completion date

2015-05-31

Last updated

2014-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Metabolic Diseases, Obstructive Sleep Apnea

Keywords

Obstructive sleep apnea, cardiometabolic complications, Effects of CPAP treatment

Brief summary

Subjects with Obstructive Sleep Apnea (OSA) are at increased risk of developing cardiometabolic complications, and effective long-term nCPAP treatment significantly reduces the risk of cardiovascular morbidity and mortality.

Detailed description

1. Primary outcome: Incidence of cardiometabolic diseases in subjects with OSA over 9 years. 2. Secondary outcomes: Effects of CPAP treatment on cardiometabolic conditions

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* From previous cohort for reassessment.

Exclusion criteria

* Unstable medical conditions

Design outcomes

Primary

Measure	Time frame	Description
Incidence of cardiometabolic complications	9 years	167 subjects recruited from our previous OSA and metabolic syndrome (OSAMS) cohort from October 2002 to June 2007 will be invited to be reassessed at this time point.

Secondary

Measure	Time frame
Effects of CPAP treatment on cardiometabolic conditions	9 years

Countries

Hong Kong

Contacts

Primary ContactJamie C Lam, MD

lamcmj@hku.hk852-22555906

Outcome results